ישראל - עברית - Ministry of Health

novartis israel ltd., israel - cefuroxime as axetil - טבליה - cefuroxime as axetil 250 mg - cefuroxime - cefuroxime - treatment of infections due to cefuroxime susceptible microorganisms.

ישראל - עברית - Ministry of Health

novartis israel ltd., israel - cefuroxime as axetil - suspension - cefuroxime as axetil 25 mg/ml - cefuroxime - cefuroxime - treatment of infections due to cefuroxime susceptible microorganisms.

ישראל - עברית - Ministry of Health

novartis israel ltd., israel - cefuroxime as axetil - suspension - cefuroxime as axetil 50 mg/ml ml - cefuroxime - cefuroxime - treatment of infections due to cefuroxime susceptible micro-organism.

ישראל - עברית - Ministry of Health

novartis israel ltd - diclofenac as potassium - טבליה - diclofenac as potassium 50 mg - diclofenac - diclofenac - management of pain and primary dysmenorrhea, when prompt pain relief is desired.

ישראל - עברית - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 100 mg; carbidopa 25 mg; entacapone 200 mg - levodopa - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

ישראל - עברית - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 50 mg; carbidopa 12.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

ישראל - עברית - Ministry of Health

novartis israel ltd - omalizumab - אבקה וממס להכנת תמיסה להזרקה - omalizumab 150 mg/dose - omalizumab - omalizumab - xolair is indicated for adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. xolair has been shown to decrease the incidence of asthma exacerbations in these patients. safety and efficacy have not been established in other allergic conditions.

ישראל - עברית - Ministry of Health

אינטרביוטי קוסמטיקס ישראל בעמ - ריכוך השיער

ישראל - עברית - Ministry of Health

אינטרביוטי קוסמטיקס ישראל בעמ - חפיפת שיער

ישראל - עברית - Ministry of Health

אינטרביוטי קוסמטיקס ישראל בעמ - טיפול השיער